Brief: China Biotech Services Announces Capital Injection In Pengbo (Hainan) Medical Technology
Aug 6 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* CAPITAL INJECTION IN AND- DEEMED DISPOSAL OF EQUITY
INTEREST IN-
PENGBO (HAINAN) MEDICAL TECHNOLOGY
* REGISTERED CAPITAL OF PENGBO (HAINAN) WOULD BE INCREASED
TO
RMB231 MILLION
* HUBEI WEIYOU TO CONTRIBUTE UP TO RMB242.3 MILLION IN
PENGBO
(HAINAN) TO SUBSCRIBE FOR 35% STAKE IN PENGBO
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)